RPC (NYSE:RES – Get Free Report) was upgraded by stock analysts at Citigroup from a “sell” rating to a “neutral” rating in a note issued to investors on Tuesday,Benzinga reports. The firm presently has a $4.75 price objective on the oil and gas company’s stock, down from their previous price objective of $5.50. Citigroup’s price target would indicate a potential upside of 7.10% from the company’s current price.
RPC Stock Up 2.7 %
Shares of NYSE:RES opened at $4.44 on Tuesday. The company’s fifty day moving average is $5.67 and its two-hundred day moving average is $6.07. The company has a market cap of $958.20 million, a P/E ratio of 10.31 and a beta of 1.27. RPC has a 12-month low of $4.10 and a 12-month high of $8.19.
RPC (NYSE:RES – Get Free Report) last announced its quarterly earnings data on Thursday, January 30th. The oil and gas company reported $0.06 EPS for the quarter, meeting analysts’ consensus estimates of $0.06. RPC had a net margin of 6.46% and a return on equity of 8.62%. Equities research analysts anticipate that RPC will post 0.31 earnings per share for the current year.
Institutional Inflows and Outflows
About RPC
RPC, Inc, through its subsidiaries, engages provision of a range of oilfield services and equipment for the oil and gas companies involved in the exploration, production, and development of oil and gas properties. The company operates through Technical Services and Support Services segments. The Technical Services segment offers pressure pumping, fracturing, acidizing, cementing, downhole tools, coiled tubing, snubbing, nitrogen, well control, wireline, pump down, and fishing services that are used in the completion, production, and maintenance of oil and gas wells.
Featured Stories
- Five stocks we like better than RPC
- Find and Profitably Trade Stocks at 52-Week Lows
- Who Led Buybacks to End 2024? Hint: It Wasn’t Big Tech
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Alibaba Caught in Tariff Crossfire: Is It Time to Buy?
- What is the Shanghai Stock Exchange Composite Index?
- Can Solid Biosciences Challenge Sarepta in the DMD Market?
Receive News & Ratings for RPC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RPC and related companies with MarketBeat.com's FREE daily email newsletter.